Line 2: |
Line 2: |
| | | |
| ==Myeloproliferative Neoplasms (MPN)== | | ==Myeloproliferative Neoplasms (MPN)== |
− | *[[Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive]] | + | |
− | *[[Chronic Neutrophilic Leukemia (CNL)]] | + | *[[HAEM5:Chronic myeloid leukaemia]] |
− | *[[Polycythemia Vera (PV)]] | + | *[[HAEM5:Chronic neutrophilic leukaemia]] |
− | *[[Primary Myelofibrosis (PMF)]] | + | *[[HAEM5:Polycythaemia vera]] |
− | *[[Chronic Eosinophilic Leukemia, Not Otherwise Specified]] | + | *[[HAEM5:Primary myelofibrosis]] |
− | *[[Myeloproliferative Neoplasm (MPN), Unclassifiable]] | + | *[[HAEM5:Chronic eosinophilic leukaemia]] |
| + | *[[HAEM5:Myeloproliferative neoplasm, NOS]] |
| *[[Some new stuff]] | | *[[Some new stuff]] |
| | | |
Line 14: |
Line 15: |
| | | |
| Put your text here | | Put your text here |
− |
| |
| | | |
| '''Cancer Category/Type''' | | '''Cancer Category/Type''' |
| | | |
− | Put your text here | + | Put your text here |
| | | |
| | | |
Line 154: |
Line 154: |
| <br /> | | <br /> |
| {| class="wikitable" | | {| class="wikitable" |
− | |'''Chr #''' | + | |'''Chr #''' |
| |'''Gain/Loss/Amp/LOH''' | | |'''Gain/Loss/Amp/LOH''' |
| |'''Minimal Region Genomic Coordinates [Genome Build]''' | | |'''Minimal Region Genomic Coordinates [Genome Build]''' |
Line 161: |
Line 161: |
| |'''Prognostic Significance''' | | |'''Prognostic Significance''' |
| | | |
− | '''(Yes, No or Unknown)''' | + | '''(Yes, No or Unknown)''' |
| |'''Therapeutic Significance''' | | |'''Therapeutic Significance''' |
| | | |
Line 238: |
Line 238: |
| |'''Prognostic Significance''' | | |'''Prognostic Significance''' |
| | | |
− | '''(Yes, No or Unknown)''' | + | '''(Yes, No or Unknown)''' |
| |'''Therapeutic Significance''' | | |'''Therapeutic Significance''' |
| | | |
Line 286: |
Line 286: |
| |'''Prognostic Significance''' | | |'''Prognostic Significance''' |
| | | |
− | '''(Yes, No or Unknown)''' | + | '''(Yes, No or Unknown)''' |
| |'''Therapeutic Significance''' | | |'''Therapeutic Significance''' |
| | | |